HC Wainwright reaffirmed their buy rating on shares of Gossamer Bio (NASDAQ:GOSS – Free Report) in a report published on Wednesday, Benzinga reports. They currently have a $5.00 price target on the stock. Separately, Wedbush reiterated an outperform rating and issued a $5.00 target price (down from $7.00) on shares of Gossamer Bio in a […]
UBS Group cut shares of Gossamer Bio (NASDAQ:GOSS – Free Report) from a buy rating to a neutral rating in a research note published on Thursday morning, Marketbeat Ratings reports. The brokerage currently has $1.25 target price on the stock, down from their previous target price of $8.00. A number of other research firms also […]
Wedbush restated their outperform rating on shares of Gossamer Bio (NASDAQ:GOSS – Free Report) in a research note released on Friday, Benzinga reports. Wedbush currently has a $7.00 price target on the stock. Gossamer Bio Stock Performance Gossamer Bio stock opened at $1.35 on Friday. The company has a debt-to-equity ratio of 17.20, a quick […]
Gossamer Bio (NASDAQ:GOSS – Get Free Report)‘s stock had its “outperform” rating reaffirmed by stock analysts at Wedbush in a research report issued on Friday, Benzinga reports. They presently have a $7.00 target price on the stock. Wedbush’s price objective indicates a potential upside of 464.52% from the stock’s current price. Gossamer Bio Trading Down […]
Gossamer Bio, Inc. (NASDAQ:GOSS – Get Free Report)’s stock price traded up 5.7% during trading on Wednesday . The company traded as high as $1.72 and last traded at $1.66. 2,494,453 shares were traded during mid-day trading, a decline of 18% from the average session volume of 3,055,566 shares. The stock had previously closed at […]